ITMCTR2024000138尚未招募Unknown
A randomized controlled clinical trial of Tongjiang Jieyu Decoction in the treatment of non-erosive gastroesophageal reflux disease overlapping functional dyspepsia
Guang'anmen Hospital of Chinese Academy of traditional Chinese medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •1: Meanwhile meet the western medical diagnosis of NERD, FD and Chinese medicine diagnostic criteria, and have the typical gastro-oesophageal reflux symptoms for more than 1 month.
- •2: Between 18 and 75 years old.
- •3: Patients who demonstrate good compliance, voluntarily and autonomously cooperate with treatment and follow-up, and sign an informed consent form.
排除标准
- •1: Patients with cardiogenic chest pain, gastric or duodenal ulcers, upper gastrointestinal malignancies, acute upper gastrointestinal bleeding, biliary diseases, or those with lesions diagnosed by endoscopy or pathology.
- •2: Patients with Helicobacter pylori infection, achalasia, pyloric obstruction, Zollinger-Ellison syndrome, post-gastroesophageal or duodenal surgery, other laboratory findings indicating organic diseases causing the condition, or other systemic diseases.
- •3: Patients with esophageal lesions caused by other reasons, such as fungal esophagitis, drug-induced esophagitis, immune-related esophagitis, eosinophilic esophagitis, esophageal cancer, etc.
- •4: Patients with severe primary cardiovascular, cerebrovascular, liver, kidney, endocrine, or hematological diseases, or other serious illnesses affecting survival.
- •5: Pregnant or lactating women, and those planning pregnancy within the next year.
- •6: Patients known to be allergic to the traditional Chinese or Western medicines used in this study or those who have previously experienced liver or kidney function impairment due to traditional Chinese medicine.
- •7: Patients who have taken acid-suppressing, prokinetic, or other medications that may affect the study results within the last two weeks.
- •8: Patients suspected of or with a history of alcohol or drug abuse, or other conditions that might reduce the likelihood of enrollment or complicate participation.
- •9: Patients with legal disabilities or mental illnesses as defined by law.
- •10: Patients currently participating in other drug clinical studies.
研究者
相似试验
尚未招募
1 期
A randomized controlled clinical study of Tonglin Guben Recipe on CIRF outcome after soft endoscopy for renal calculirenal calculusITMCTR2200006638The Second Affiliated Hospital of Guangzhou University of traditional Chinese Medicine
招募中
1 期
Clinical application study of Yijinjing in preventing and treating knee osteoarthritisKnee osteoarthritisITMCTR2000003995Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
招募中
1 期
A randomized controlled trial for Shugan Tiaoshen integrated program of acupuncture and moxibustion in the treatment of moderate depressive disorderDepressive disorderITMCTR2100004351Guangdong Hospital of traditional Chinese Medicine
尚未招募
1 期
A Randomized Controlled Trial for Modified Tongnaohuoluo Acupuncture in Treating Dysphagia Caused by Pseudobulbar Paralysis (Phlegm and Blood Stasis Type) After StrokeStrokeITMCTR2000003197Wuxi People's Hospital
招募中
1 期
A randomized controlled clinical study of Qinghua Zhixie Recipe in Treating Irritable Bowel Syndrome with Spleen Deficiency and Damp-HeatIrritable Bowel SyndromeITMCTR2000003959Changshu Hospital of Traditional Chinese Medicine